As expected, we confirmed that JP1 regulates mitochondrial metabolic reprogramming of B16F10 and LLC cells through JP1-mediated AMPK/FOXO3a/UQCRC2 signaling, thereby improving the hypoxic state of the tumor microenvironment (Supplemental Figure 6D). Here, FOXO3 is linked to neoplasm.